Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes

American Journal of Veterinary Research

Volumn 63, Issue 11, 2002, Pages 1512-1519

  Tesch, Anthony M ^a   MacDonald, Melinda H ^a   Kollias Baker, Cynthia ^a   Benton, Hilary P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' IODOTUBERCIDIN; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE INHIBITOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME METABOLISM; HORSE; INCUBATION TIME; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; MONOLAYER CULTURE; NONHUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUPERNATANT; TIME;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI;

EID: 0036847461     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1512     Document Type: Article

References (51)

1. Moulton PJ. Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species. Br J Biomed Sci 1996;53:317-324.
2. Attur MG, Dave M, Akamatsu M, et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002;10:1-4.
3. Firestein GS, Bullough DA, Erion MD, et al. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol 1995;154:326-334.
4. 2 receptor on human neutrophils. J Immunol 1985;135:1366-1371.
5. Cronstein BN, Kramer SB, Weissmann G, et al. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983;158:1160-1177.
6. Lennon PF, Taylor CT, Stahl GL, et al. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 1998;188:1433-1443.
7. Schrier DJ, Lesch ME, Wright CD, et al. The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J Immunol 1990;145:1874-1879.
8. Szabo C, Scott GS, Virag L, et al. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998;125:379-387.
9. Le Vraux V, Chen YL, Masson I, et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 1993;52:1917-1924.
10. Hasko G, Szabo C, Nemeth ZH, et al. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996;157:4634-4640.
11. Abbracchio MP, Burnstock G. Purinergic signaling: pathophysiological roles. Jpn J Pharmacol 1998:113-145.
12. 2 release. Arthritis Rheum 1999;42:258-267.
13. 2 release from human rheumatoid synovial cells. Arthritis Rheum 1998;41:246-255.
14. Boyle DL, Fereydoun GS, Firestein GS. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 1996;39:923-930.
15. Bowler WB, Buckley KA, Gartland A, et al. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone 2001;28:507-512.
16. Tucker AL, Linden J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res 1993;27:62-67.
17. Benton HP, MacDonald MH, Tesch AM. Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes. Am J Vet Res 2002; 63:204-210.
18. 2 receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthritis Cartilage 2002;10:34-43.
19. Schaeffer HJ, Schwender CF. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. J Med Chem 1974;17:6-8.
20. Ugarkar BG, Castellino AJ, DaRe JM, et al. Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues. J Med Chem 2000;43:2894-2905.
21. Kowaluk EA, Jarvis MF. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 2000;9:551-564.
22. Ugarkar BG, DaRe JM, Kopcho JJ, et al. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodombercidin analogues. J Med Chem 2000;43:2883-2893.
23. Rosengren S, Bong GW, Firestein GS. Anti-inflamamatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol 1995;154:5444-5451.
24. Kowaluk EA, Mikusa J, Wismer CT, et al. ABT-702 (4-amino-5-(3-bromophenyl) - 7- (6-morpholino-pyriclin -3 -yl)pyrido [2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J Pharmacol Exp Ther 2000;295:1165-1174.
25. Cronstein BN, Naime D, Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 1995;38:1040-1045.
26. McGaraughty S, Chu KL, Wismer CT, et al. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action. J Pharmacol Exp Ther 2001;296:501-509.
27. Boyle DL, Kowaluk EA, Jarvis MF, et al. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmacol Exp Ther 2001;296:495-500.
28. MacDonald MH, Stover SM, Willits NH, et al. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. Am J Vet Res 1992;53:2278-2285.
29. Koolpe M, Rodrigo JJ, Benton HP. Adenosine 5′-triphosphate, uridine 5′-triphosphate, bradykinin, and lysopbosphatidic acid induce different patterns of calcium responses by human articular chondrocytes. J Orthop Res 1998;16:217-226.
30. MacDonald MH, Tesch AM, Benton HP, et al. Characterization of age and location associated variations in the composition of articular cartilage from the equine metacarpophalangeal joint. J Equine Vet Sci 2002;22:25-32.
31. Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989;49:4435-4440.
32. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
33. Stadler J, Stefanovic-Racic M, Billiar TR, et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991;147:3915-3920.
34. Stefanovic-Racic M, Morales TI, Taskiran D, et al. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 1996,156:1213-1220.
35. Lipman JM. Fluorophotometric quantitation of DNA in articular cartilage utilizing Hoechst 33258. Anal Biochem 1989;176:128-131.
36. Morabito L, Montesinos MC, Schreibman DM, et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 1998;101:295-300.
37. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001;24:31-55.
38. Poon A, Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 1998;74:235-245.
39. Ballarin M, Fredholm BB, Ambrosio S, et al. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 1991;142:97-103.
40. Pak MA, Haas HL, Decking UK, et al. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 1994;33:1049-1053.
41. Zhu PJ, Krnjevic K. Endogenous adenosine deaminase does not modulate synaptic transmission in rat hippocampal slices under normoxic or hypoxic conditions. Neuroscience 1994;62:489-497.
42. Graff RD, Lazarowski ER, Banes AJ, et al. ATP release by mechanically loaded porcine chondrons in pellet culture. Arthritis Rheum 2000;43:1571-1579.
43. Murrell GA, Doland MM, Jang D, et al. Nitric oxide: an important articular free radical. J Bone Joint Surg Am 1996;78:265-274.
44. Jang D, Murrell GA. Nitric oxide in arthritis. Free Radic Biol Med 1998;24:1511-1519.
45. 2. Exp Cell Res 1995;218:319-325.
46. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 1995;210:93-101.
47. Hauselmann HJ, Stefanovic-Racic M, Michel BA, et al Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J Immunol 1998;160:1444-1448.
48. Johnson K, Jung A, Murphy A, et al. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000;43:1560-1570.
49. Tomita M, Sato EF, Nishikawa M, et al. Nitric oxide regulates mitochondrial respiration and functions of articular chondrocytes. Arthritis Rheum 2001;44:96-104.
50. Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996;35:207-212.
51. Frean SP, Bryant CE, Froling IL, et al. Nitric oxide production by equine articular cells in vitro. Equine Vet J 1997;29:98-102.